Key References
- Gallagher, CJ Oliver, RDT Oram, DH Fowler, CG Blake, PR Mantell, BS Slevin, ML Hope-Stone, HF A new treatment for endometrial cancer with gonadotropin-releasing hormone analogue. Br. J. Obstet. Gynaecol. 1991 98 1037–1041.
- Flouret, G Mahan, K Majewski, T Decreased histamine release by luteinizing hormone-releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7. J. Med. Chem. 1992 35 636–640.
- Adams, LA Bremner, WJ Nestor, JJ Vickery, BH Steiner, RA Suppression of gondotropins and testosterone in adult male monkeys Macaca fascicularis by a potent inhibitory analogue of gonadotropin-releasing hormone. J. Clin. Endocr. Metab. 1986 62 58–63.
- Andreyko, JL Monroe, SE Marshall, LA Fluker, MR Nerenberg, CA Jaffe, RB Concordant suppression of serum immunoreactive lutinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist Detirelix J. Clin. Endocr. Metab. 1992 74 399–405.
- Reissmann, T Hilgard, P Harleman, JH Engel, J Comaru-Schally, AM Schally, AV Treatment of experimental DMBA induced mammary carcinoma with Cetro relix (SB-75): A potent antagonist of luteinizing hormone-releasing hormone. J. Cancer Res. Clin. Oncol. 1992 118 44–49.
- Reading, TW Schally, AV Radulovic, S Milovanovic, S Szepeshazi, K Issacs, JT Sustained release formulations of luteinizing hormone-release hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-12) in male nude mice. 1992 52 2538–2544.
- Segal-Abramson, T Kitroser, H Levy, J Schally, AV Sharoni, Y Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells. Proc. Natl. Acad. Sci. USA 1992 89 2336–2339.